Distinct metabolic responses of an ovarian cancer stem cell line

BMC Systems Biology

Volumn 8, Issue 1, 2014, Pages

  Vermeersch, Kathleen A ^a   Wang, Lijuan ^b   McDonald, John F ^b   Styczynski, Mark P ^a  

^a Georgia Institute of Technology   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Biologically inspired metabolic perturbations; Cancer metabolism; Cancer stem cells; Metabolomics; Ovarian cancer

Indexed keywords

DOCETAXEL; TAXOID;

CANCER STEM CELL; CELL HYPOXIA; FEMALE; HUMAN; IN VITRO STUDY; MASS SPECTROMETRY; METABOLISM; OVARY TUMOR; PHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

CELL HYPOXIA; CELL LINE, TUMOR; FEMALE; HUMANS; IN VITRO TECHNIQUES; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; TAXOIDS; TUMOR MICROENVIRONMENT;

EID: 85027932352     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/s12918-014-0134-y     Document Type: Article

References (24)

1. Warburg O: Origin of Cancer Cells. Science 1956, 123:309-314.
2. Warburg O, Posener K, Negelein E: On the metabolism of carcinoma cells. Biochem Z 1924, 152:309-344.
3. Hanahan D, Weinberg RA: Hallmarks of cancer: The next generation. Cell 2011, 144:646-674.
4. Kroemer G, Pouyssegur J: Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.
5. Menendez JA, Oliveras-Ferraros C, Cufi S, Corominas-Faja B, Joven J, Martin-Castillo B, Vazquez-Martin A: Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle 2012, 11:2782-2792.
6. Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-768.
7. Alison MR, Lim SML, Nicholson LJ: Cancer stem cells: Problems for therapy? J Pathol 2011, 223:147-161.
8. Medema JP: Cancer stem cells: The challenges ahead. Nat Cell Biol 2013, 15:338-344.
9. Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF: Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Mol Cell Biochem 2012, 363:257-268.
10. Vermeersch KA, Wang L, Mezencev R, McDonald JF, Styczynski MP: OVCAR-3 spheroid-derived cells display distinct metabolic profiles. PLoS ONE 2014, in press. DOI: 10.1371/journal.pone.0118262.
11. Li CP, Chen JS, Chen LT, Yen CJ, Lee KD, Su WP, Lin PC, Lu CH, Tsai HJ, Chao Y: A phase II study ofweekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer. Br J Cancer 2010, 103:1343-1348.
12. Shimasaki T, Miyazawa K, Moriyama M, Tanaka T, Sato I, Nakaya N, Nakajima H, Kubo A, Suzuki K, Motoo Y: [Combination chemotherapy of docetaxel and UFT against hormone refractory prostate cancer]. Hinyokika Kiyo Acta Urologica Japonica 2011, 57:163-166.
13. Tsuchiya A, Imai M, Kamimura H, Togashi T, Watanabe K, Seki K, Ishikawa T, Ohta H, Yoshida T, Kamimura T: Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil. World J Gastroenterol 2009, 15:1779-1781.
14. Yang KC, Chao Y, Luo JC, Kuo JY, Lee RC, Li AF, Li CP: The unusual presentation of gastric adenocarcinoma as a testicular mass: A favorable response to docetaxel and Cisplatin plus oral tegafur/uracil and leucovorin. J Chin Med Assoc 2010, 73:88-92.
15. Ferreira AK, Freitas VM, Levy D, Ruiz JL, Bydlowski SP, Rici RE, Filho OM, Chierice GO, Maria DA: Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine. PLoS One 2013, 8:e57937.
16. Ferreira AK, Meneguelo R, Pereira A, Filho OM, Chierice GO, Maria DA: Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway. Biomed Pharmacother 2013, 67:481-487.
17. Cabarcas SM, Mathews LA, Farrar WL: The cancer stem cell niche-there goes the neighborhood? Int J Cancer 2011, 129:2315-2327.
18. Li Z, Rich JN: Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. Curr Top Microbiol Immunol 2010, 345:21-30.
19. Yvon A-MC, Wadsworth P, Jordan MA: Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell 1999, 10:947-959.
20. Lu X, Bennet B, Mu E, Rabinowitz J, Kang Y. Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. J Biol Chem2010, 285:9317-9321.
21. Kind T, Wohlgemuth G, Lee DY, Lu Y, Palazoglu M, Shahbaz S, Fiehn O: FiehnLib: Mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem 2009, 81:10038-10048.
22. Wei X, Shi X, Koo I, Kim S, Schmidt RH, Arteel GE, Watson WH, McClain C, Zhang X: MetPP: A computational platform for comprehensive twodimensional gas chromatography time-of-flight mass spectrometrybased metabolomics. Bioinformatics (Oxford, England) 2013, 29:1786-1792.
23. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, Brown M, Knowles JD, Halsall A, Haselden JN, Nicholls AW, Wilson ID, Kell DB, Goodacre R: Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011, 6:1060-1083.
24. Xia JG, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS: MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res 2012, 40:W127-W133.